MedTrace Logo

Strategies to Improve Bone Health in Men on ADT

NCT02043236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2018-03-22

No results posted yet for this study

Summary

This is a phase II randomized controlled trial (RCT) of 2 strategies to improve bone health in men receiving androgen deprivation therapy (ADT).

Conditions

Interventions

BEHAVIORAL

Healthy bones pamphlet

written educational material

BEHAVIORAL

Bone Health Care Coordinator

The Bone Health Care Coordinator reviews educational materials with participant and facilitates ordering BMD.

BEHAVIORAL

Letter to GP

The letter to the General Practitioner contains information about the study, recommendations for bone health, guidelines of Osteoporosis Canada, and the identical educational material that the participant received.

Sponsors & Collaborators

  • Canadian Cancer Society (CCS)

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Shabbir Alibhai, MD · UHN

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02043236 on ClinicalTrials.gov